Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
10.03.26
/
50%
€429.85
Target price
10.03.27
€512.68
Performance (%)
6.15%
Price
12.08.26
€456.30
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 6.15%. This prediction currently runs until 10.03.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 8.656% | 8.656% |
| iShares Core DAX® | 0,63 % | 4,95 % |
| iShares Nasdaq 100 | 1,16 % | -1,16 % |
| iShares Nikkei 225® | 2,36 % | -1,35 % |
| iShares S&P 500 | 0,63 % | 1,38 % |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (VRTX) had its price target raised by Morgan Stanley from $570.00 to $596.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.25
05.05.26
05.05.26
€527.05
05.05.27
05.05.27
27.73%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.55
10.04.26
10.04.26
€523.50
10.04.27
10.04.27
22.81%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€420.00
13.02.26
13.02.26
-
13.02.27
13.02.27
8.64%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
21.39%
12.08.26
12.08.26